Form 4 for VCYT VERACYTE, INC.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001384101-21-000155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-09 | 2021-09-07+ | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $50.55 | -13.5K | 50.0K | -21% | -$680.2K |
| DM | 2021-09-09 | 2021-09-07 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $16.77 | +12.5K | 59.1K | +27% | +$210.2K |
| DM | 2021-09-09 | 2021-09-07 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $0.00 | -12.5K | 22.5K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 12,034 | $50.52 | 51,472 | D | — | — | (F2) Represents weighted average sales price. Sale prices for the transactions range from $50.06 to $51.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| 2 | Common | Common Stock | 2021-09-07 | S | D | 497 | $51.23 | 50,975 | D | — | — | (F3) Represents weighted average sales price. Sale prices for the transactions range from $51.07 to $51.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| 3 | Common | Common Stock | 2021-09-07 | M | A | 4,375 | $24.69 | 63,506 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-08 | S | D | 926 | $50.53 | 50,049 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-07 | M | A | 4,406 | $5.98 | 55,381 | D | — | — | |
| 6 | Common | Common Stock | 2021-09-07 | M | A | 3,750 | $20.21 | 59,131 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2021-09-07 | M | D | 4,375 | $0.00 | 43,750 | D | $24.69 · — to 2030-03-27 | 4,375 Common Stock | (F6) The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. |
| 8 | Derivative | Stock Option (right to buy) | 2021-09-07 | M | D | 4,406 | $0.00 | 8,813 | D | $5.98 · — to 2028-03-01 | 4,406 Common Stock | (F4) The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. |
| 9 | Derivative | Stock Option (right to buy) | 2021-09-07 | M | D | 3,750 | $0.00 | 22,500 | D | $20.21 · — to 2029-02-27 | 3,750 Common Stock | (F5) The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. |